Skip to main content

Table 4 EORTC-C30 and -BN20 domain and single item's scores before and 6 months after VMAT

From: Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life

QoL Pre-VMAT score ± SD Score during VMAT ± SD p value
C30    
Global Health Status 62.5 ± 26.4 68.8 ± 20.8 0.47
Physical functioning 78.9 ± 22.9.6 71.9 ± 26.0 0.72
Emotional functioning 74.8 ± 20.1 70.0 ± 41.5 0.89
Role functioning 75.0 ± 21.6 73.3 ± 41.8 0.72
BN20 domains/items    
Domains    
Future uncertainty 26.0 ± 23.5 30.0 ± 41.5 0.72
Visual disorder 15.5 ± 12.7 28.9 ± 36.5 0.41
Motor dysfunction 15.5 ± 16.8 24.4 ± 30.8 0.59
Communication deficit 22.2 ± 28.3 6.6 ± 6.1 0.29
Single items    
Headache 26.7 ± 43.5 20.0 ± 29.8 0.99
Hair loss 13.3 ± 29.8 0.0 ± 0.0 0.32
Weakness of legs 20.0 ± 18.2 26.6 ± 27.9 0.66
Bladder control 0.0 ± 0.0 0.0 ± 0.0 1.00
  1. Abbreviations: QoL: Quality of life; SD, standard deviation.